Presentation given to our fellowship program about diabetic kidney disease.
2022 update discussing SGLT2i, MRA (e.g. finerenone), health economics and beyond
Presentation given to our fellowship program about diabetic kidney disease.
2022 update discussing SGLT2i, MRA (e.g. finerenone), health economics and beyond
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/i_bUFU-p43Q
Arabic Language version of this lecture is available at:
https://youtu.be/RaIP09m4XMY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of the lecture:
English Language version of this lecture is available at: https://youtu.be/-Ynxvhbcl7U
Arabic Language version of this lecture is available at: https://youtu.be/QpK_toctVlw
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...Dr. Om J Lakhani
Talk on MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of Metformin In CKD).
Presented on 25th June 2017 at THE METFORMIN MEET in Vadodara, India
Slidedeck of the presentation I gave during the East by Southwest conference, co-organized by the Division of Nephrology (UNM) and the Renal and Electrolyte Division (UPMC)
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/NQMiLXb0AXk
Arabic Language version of this lecture is available at:
https://youtu.be/o_I9bzxcJoQ
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/lvcXwE0fb-w
- Arabic version of this lecture is available at:
https://youtu.be/r-fG8bSCqZo
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/i_bUFU-p43Q
Arabic Language version of this lecture is available at:
https://youtu.be/RaIP09m4XMY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of the lecture:
English Language version of this lecture is available at: https://youtu.be/-Ynxvhbcl7U
Arabic Language version of this lecture is available at: https://youtu.be/QpK_toctVlw
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...Dr. Om J Lakhani
Talk on MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of Metformin In CKD).
Presented on 25th June 2017 at THE METFORMIN MEET in Vadodara, India
Slidedeck of the presentation I gave during the East by Southwest conference, co-organized by the Division of Nephrology (UNM) and the Renal and Electrolyte Division (UPMC)
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/NQMiLXb0AXk
Arabic Language version of this lecture is available at:
https://youtu.be/o_I9bzxcJoQ
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/lvcXwE0fb-w
- Arabic version of this lecture is available at:
https://youtu.be/r-fG8bSCqZo
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Paper sobre Modularidad basado en el libro “Object-Oriented Software Construction” de Bertrand Meyer. Contiene un acercamiento al tema de una forma menos técnica que en el magnifico libro.
This is an academic assignment on performance management, setting up tasks and priorities. It aims to define tasks in terms of behaviors and develops criteria standards.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Approach to chronic kidney disease
1. DR.Basma M Abd El Aziz ,Family Medicine,SCU
Presented by
Dr. Basma Mohamed Abd El Aziz
Assistant lecture of family medicine
2013
Approach to patient with
chronic kidney disease
2. DR.Basma M Abd El Aziz ,Family Medicine,SCU
How many patient you seeHow many patient you see
have CKDhave CKD
3. DR.Basma M Abd El Aziz ,Family Medicine,S
38%
Prevalence among patients with end-stage
renal disease in 2010
Diabetic kidney disease
4. DR.Basma M Abd El Aziz ,Family Medicine,S
Objective
Definition
Screening
Etiology
Classification
staging
Clinical evaluation
Management
When to refer
5. DR.Basma M Abd El Aziz ,Family Medicine,SCU
What is chronic kidneyWhat is chronic kidney
diseasedisease??
6. DR.Basma M Abd El Aziz ,Family Medicine,S
CKD: definition
1- Glomerular filtration rate (GFR) < 60mL/min/1.73m2 that is
present for > 3 months with or without evidence of kidney
damage,
oror
2- Evidence of kidney damage with or without decreased GFR
that is present for > 3 months as evidenced by any of the
following:
– microalbuminuria, proteinuria, – glomerular haematuria.
– pathological abnormalities (e.g. abnormal renal biopsy)
– anatomical abnormalities(e.g. scarring seen on imaging
or polycystic kidneys)
7. DR.Basma M Abd El Aziz ,Family Medicine,S
The serum creatinine alone is not an
accurate measure of glomerular filtration
rate.
Normal ranges for serum creatinine are
misleading because they do not take into
account the age, sex, or weight of the
patient.
Why can’t I just use the serum creatinine?
8. DR.Basma M Abd El Aziz ,Family Medicine,S
Cockcroft-Gault equation :-
[[140 - age(yr)]*weight(kg)]/[72*serum Cr(mg/dL)]
(0.85 for women)
MDRD equation 7 :-
170 * [serum creatinine (mg/dL)]-0.999 * [age (years)]-
0.176 * [0.762 if pt is female] * [1.180 if pt is black] *
[BUN(mg/dL)]-0.170 * [albumin (g/dL)] +0.318
Equations for Estimating the GFR
9. DR.Basma M Abd El Aziz ,Family Medicine,S
Consider the following two patients with identical
serum creatinines of 1.2 mg/dL.
Patient 1- a 60 year old 50 kg woman
Patient 2- a 30 year old 90 kg man
The first patient has a GFR of 39 ml/min/1.73 m2,
which is markedly abnormal,
…………………………..while the second has a GFR of
115 ml/min/1.73 m2,well within the normal range.
Clinical example
10. DR.Basma M Abd El Aziz ,Family Medicine,SCU
Stages of CKD
12. DR.Basma M Abd El Aziz ,Family Medicine,S
Screening of CKDScreening of CKD
13. DR.Basma M Abd El Aziz ,Family Medicine,S
Annual CKD screening is
recommended by
the American Diabetes Association,
the National Kidney Foundation for patients at risk,
the Joint National Committee on Hypertensionf or
patients with diabetes and hypertension
the American Heart Association for patients with
cardiovascular disease.
The USPSTF concludes that the evidence is insufficient
to assess the balance of benefits and harms of routine
screening for chronic kidney disease in asymptomatic
adults.Grade: I Statement.
14. DR.Basma M Abd El Aziz ,Family Medicine,S
SCREENING TESTS
CKD is typically detected by measuring
serum creatinine levels to calculate the GFR .
urinary albumin/creatinine ratio to detect
proteinuria.
Urinalysis.
AFFP ,2011
15. DR.Basma M Abd El Aziz ,Family Medicine,S
RISK FACTORS
Older age
Family history of CKD
Minority status (e.g., blacks, American Indians, Asians, Pacific Islanders
Exposure to certain chemicals and environmental conditions (e.g., lead, cadmium,
arsenic, mercury, uranium )Exposure to certain drugs (
Hypertension
Diabetes mellitus
Low birth weight
Low income or education
Lower urinary tract obstruction
Neoplasia
Nephrolithiasis
Recovery from acute kidney injury
Reduction in kidney mass
Urinary tract infections
Systemic infections
Autoimmune disease
16. DR.Basma M Abd El Aziz ,Family Medicine,SCU
Causes of chronic kidneyCauses of chronic kidney
diseasedisease
21. DR.Basma M Abd El Aziz ,Family Medicine,S
MicroalbuminuriaMicroalbuminuria
Patients with albumin/ creatinine ratios of 30 to
300 mg per g
MacroalbuminuriaMacroalbuminuria
those with ratios greater than 300 mg per g
22. DR.Basma M Abd El Aziz ,Family Medicine,SCU
Investigation andInvestigation and
clinical evaluationclinical evaluation
23. DR.Basma M Abd El Aziz ,Family Medicine,S
Clinical pictureClinical picture
29. DR.Basma M Abd El Aziz ,Family Medicine,S
Clinical intervention of CKD
30. DR.Basma M Abd El Aziz ,Family Medicine,S
GFR is less than 30 mL per minute per 1.73 m2
severe cardiovascular disease.
Anemia of CKD
Bone and mineral disorder of CKD
Difficult to manage adverse effects of medications
Hyperkalemia (potassium level > 5.5 mEq per L [5.50 mmol per L] despite
treatment)
Refractory proteinuria (urinary protein/creatinine ratio > 500 to 1,000 mg per
g or urinary albumin/creatinine ratio > 300 mg per g)
Resistant hypertension (target blood pressure not achieved with use of at least
three antihypertensive drugs)
Stage 4 CKD (estimated GFR < 30 mL per minute per 1.73 m2)
Unexplained decrease in estimated GFR > 30 percent over four months
Indications for referral to a Nephrologist